Effect of prior beta-blocker use on in-hospital atrial fibrillation development in patients with ST-elevation myocardial infarction

被引:0
作者
Kahraman, Fatih [1 ]
Arslan, Akif [2 ]
Dogan, Abdullah [3 ]
Turker, Yasin [4 ]
Guler, Serdar [5 ]
机构
[1] Evliya Celebi Res & Training Hosp, Cardiol Clin, Kutahya, Turkey
[2] Private Anatolia Hosp, Cardiol Clin, Antalya, Turkey
[3] Private Alfa Med Ctr, Cardiol Clin, Izmir, Turkey
[4] Private Meddem Hosp, Cardiol Clin, Ispart, Turkey
[5] Acipayam State Hosp, Cardiol Clin, Denizli, Turkey
关键词
Atrial fibrillation; beta-blockers; ST-elevation myocardial infarction; mortality; arrhythmias; CLINICAL-OUTCOMES; METOPROLOL; THERAPY; CARVEDILOL; PROGNOSIS; SURVIVAL; SIZE;
D O I
10.1080/10641963.2022.2029473
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Aim There are conflicting results about the early administration of beta-blockers (bb) on in-hospital mortality and arrhythmias. Here, we wanted to investigate the effects of chronic bb use on in-hospital Atrial Fibrillation (AF) development in ST-Elevation Myocardial Infarction (STEMI) patients. Materials and Methods A total of 814 consecutive patients with STEMI were included in the study. They were divided into two groups according to whether they are using bb on admission or not. They were followed for AF development in-hospital and predictors of AF were determined by multivariable logistic regression analysis. Results Of the 814 patients, 103 (12.67%) patients were already using bb, while 711 (87.3%) were not. There were no significant differences in the frequency of AF development [3 (%2.9) vs 30 (%4.2), p = .788] between the groups. Multivariable logistic regression analysis showed that left atrial (LA) diameter is the only independent predictor of in-hospital AF development. Conclusions Our study showed that chronic bb use does not have an effect on in-hospital AF development in STEMI patients. Nevertheless, LA diameter was found to be an independent predictor of AF.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 26 条
  • [1] Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction
    Anzai, T
    Yoshikawa, T
    Takahashi, T
    Maekawa, Y
    Okabe, T
    Asakura, Y
    Satoh, T
    Mitamura, H
    Ogawa, S
    [J]. CARDIOLOGY, 2003, 99 (01) : 47 - 53
  • [2] Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction
    Batra, Gorav
    Lindhagen, Lars
    Andell, Pontus
    Erlinge, David
    James, Stefan
    Spaak, Jonas
    Oldgren, Jonas
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (03):
  • [3] All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome
    Batra, Gorav
    Svennblad, Bodil
    Held, Claes
    Jernberg, Tomas
    Johanson, Per
    Wallentin, Lars
    Oldgren, Jonas
    [J]. HEART, 2016, 102 (12) : 926 - U54
  • [4] Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial)
    Califf, Robert M.
    Lokhnygina, Yuliya
    Velazquez, Eric J.
    McMurray, John J. V.
    Leimberger, Jeffrey D.
    Lewis, Eldrin F.
    Diaz, Rafael
    Murin, Jan
    Pfeffer, Marc A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (02) : 151 - 157
  • [5] Chen ZM, 2005, LANCET, V366, P1622
  • [6] Sample size determination for logistic regression revisited
    Demidenko, Eugene
    [J]. STATISTICS IN MEDICINE, 2007, 26 (18) : 3385 - 3397
  • [7] IMPACT OF ATRIAL-FIBRILLATION ON THE IN-HOSPITAL AND LONG-TERM SURVIVAL OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A COMMUNITY-WIDE PERSPECTIVE
    GOLDBERG, RJ
    SEELEY, D
    BECKER, RC
    BRADY, P
    CHEN, ZY
    OSGANIAN, V
    GORE, JM
    ALPERT, JS
    DALEN, JE
    [J]. AMERICAN HEART JOURNAL, 1990, 119 (05) : 996 - 1001
  • [8] Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction
    Harjai, KJ
    Stone, GW
    Boura, J
    Grines, L
    Garcia, E
    Brodie, B
    Cox, D
    O'Neill, WW
    Grines, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (06) : 655 - 660
  • [9] HAVERKAMP W, 1990, BASIC RES CARDIOL, V85, P293
  • [10] Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial)
    Herlitz, J
    Waagstein, F
    Lindqvist, J
    Swedberg, K
    Hjalmarson, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (9B) : J40 - J44